  Chronic respiratory<disease> diseases<disease> remain a major cause of morbidity and mortality worldwide. The only option at end-stage disease is lung transplantation , but there are not enough donor lungs to meet clinical demand. Alternative options to increase tissue availability for lung transplantation are urgently required to close the gap on this unmet clinical need. A growing number of tissue engineering approaches are exploring the potential to generate lung tissue